Remove Adverse Reactions Remove Events Remove FDA
article thumbnail

Gabapentin side effects in men

The Checkup by Singlecare

In fact, its kind of a jack-of-all-trades drug, approved by the Food and Drug Administration (FDA) to treat epilepsy, postherpetic neuralgia, and restless leg syndrome. Research backs up the idea that women are actually more likely to experience gabapentins adverse effects than men. Those side effects, however, are largely similar.

article thumbnail

Does rosuvastatin cause hair loss?

The Checkup by Singlecare

Rosuvastatin calcium ( generic Crestor ) is a prescription medication that’s FDA approved to lower LDL cholesterol levels and triglycerides, slow the progression of atherosclerosis (hardening of the arteries), and reduce the risk of heart attack and stroke in at-risk patients. of all rosuvastatin reactions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

Drug Topics

The FDA approved clesrovimab-cfor (Enflonsia) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants born during or entering their first RSV season, Merck announced in a release. The most common adverse reactions were injection-site erythema, injection-site swelling and rash.

FDA 430
article thumbnail

FDA Issues Complete Response Letter to Manufacturer of OLC, Treatment for CKD-Related Hyperphosphatemia

Pharmacy Times

Common adverse reactions included gastrointestinal issues, with a low discontinuation rate due to adverse drug reactions. Common adverse reactions included gastrointestinal issues, with a low discontinuation rate due to adverse drug reactions.

FDA 73
article thumbnail

Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer

Pharmacy Times

Mitomycin intravesical solution (Zusduri, UroGen Pharma) was approved by the FDA for treatment of adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

FDA 65
article thumbnail

Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease

Pharmacy Times

SHOW MORE FDA approves a new dosing schedule for donanemab, enhancing safety and efficacy in treating early symptomatic Alzheimer disease. This advancement provides healthcare professionals with improved confidence in managing Alzheimer's disease with donanemab.

article thumbnail

Is compounded semaglutide safe?

The Checkup by Singlecare

In fact, the Food and Drug Administration (FDA) says consumers should exercise a lot of caution when considering using a compounded drug. Ozempic is arguably the most popular semaglutide drug, not because of its FDA-approved use for treating Type 2 diabetes but because of the amount of weight people have lost while taking it.